comparemela.com

Latest Breaking News On - பிரான்சிஸ்கோ கிமினெஸ் - Page 1 : comparemela.com

Gilead s Kite bets on early-stage biotech to advance allogeneic cell therapies

Gilead s Kite bets on early-stage biotech to advance allogeneic cell therapies
biopharmadive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biopharmadive.com Daily Mail and Mail on Sunday newspapers.

Appia Bio Launches With $52 Million Series A Financing and Establishes Scientific Advisory Board

Appia Bio Launches With $52 Million Series A Financing and Establishes Scientific Advisory Board Proceeds will be used to progress stem cell derived CAR-engineered invariant natural killer T cells (CAR-iNKT) to the clinic in hematological and solid tumor indications News provided by Share this article Share this article LOS ANGELES, May 11, 2021 /PRNewswire/ Appia Bio, Inc., an early stage biotechnology company developing engineered allogeneic cell therapies from hematopoietic stem cells (HSCs) for cancer patients, today announced its launch from stealth backed by $52 million Series A financing led by 8VC. Other investors included Two Sigma Ventures, among others, and participation from seed investors Sherpa Healthcare Partners and Freeflow Ventures.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.